BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Factor Bioscience Files Patent Infringement Lawsuit Against Cellectis and AstraZeneca

Factor Bioscience Inc. (Factor), a Cambridge, Massachusetts-based biotechnology company focused on using its pioneering gene-editing platform to devel...

September 29, 2025 | News

Mednovo Doses First Patient in Phase III Trial of Targeted Radiotherapeutic for GEP-NETs

Mednovo Group Co., Ltd. ("Mednovo") announced that the first patient has been successfully dosed in its Phase III clinical trial of Lutetium [177Lu] Oxodot...

September 12, 2025 | News

CAS Introduces CAS IP Finder™, an AI-Enhanced Solution to Transform Intellectual Property Search

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announces the introduction of CAS IP Finder, powered by S...

September 10, 2025 | News

Cartherics Secures Chinese Patent for Gene-Edited Immune Cell Therapy Targeting Solid Tumours

Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies f...

August 27, 2025 | News

iNtRON Bio Files Patents for Groundbreaking IMPA™ Gene-Editing Technology Targeting Pasteurella Bacteriophages

Development of gene-editing technology for Pasteurella bacteriophages using the IMPA™ platform Establishment of an advanced platform tec...

August 27, 2025 | News

IQVIA and Veeva Forge Global Clinical and Commercial Partnerships, Resolve Legal Disputes

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Und...

August 19, 2025 | News

Genprex Secures Key U.S. and European Patents for REQORSA® Gene Therapy in Combination with Checkpoint Inhibitors

Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced t...

August 19, 2025 | News

KBP Biosciences Welcomes Court’s Decision to Maintain Injunction Pending Arbitration with Novo Nordisk

KBP Biosciences Pte. Ltd. issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the te...

August 13, 2025 | Regulatory

Hoth Therapeutics Secures Japan Patent for HT-KIT Splice-Switching Platform Targeting Mast Cell Disorders

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained...

June 13, 2025 | News

SK Bioscience Wins Supreme Court Patent Battle Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that it the Supreme C...

May 22, 2025 | News

Hyundai ADM Bio Withdraws IND for Penetrium™/Docetaxel and Pivots to Immunotherapy Combinations

Hyundai ADM Bio announced the voluntary withdrawal of its Investigational New Drug (IND) application for Phase 1 clinical trial evaluating Pene...

May 14, 2025 | News

SK Bioscience Wins Patent Case Against Moderna Clearing Path for Global mRNA Vaccine Development

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has won...

April 24, 2025 | News

Patent Wars and Patient Lives: Inside Roche vs Natco Over Risdiplam

In a courtroom packed with legal heavyweights, global pharmaceutical giant F. Hoffmann-La Roche AG faced off against Indian generic manufac...

April 14, 2025 | Analysis

Darnatein Secures First International Patent in China for AI-Engineered Osteoarthritis Drug Technology

Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international pat...

April 10, 2025 | News

Stay Connected